242 related articles for article (PubMed ID: 26819313)
1. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
[TBL] [Abstract][Full Text] [Related]
2. T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells.
Sabbah S; Jagne YJ; Zuo J; de Silva T; Ahasan MM; Brander C; Rowland-Jones S; Flanagan KL; Hislop AD
Blood; 2012 Mar; 119(9):2083-92. PubMed ID: 22234686
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
4. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
5. Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.
Williamson SJ; Nicol SM; Stürzl M; Sabbah S; Hislop AD
PLoS Pathog; 2016 Nov; 12(11):e1006042. PubMed ID: 27893813
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.
Zuo J; Hislop AD; Leung CS; Sabbah S; Rowe M
J Virol; 2013 May; 87(10):5340-50. PubMed ID: 23449805
[TBL] [Abstract][Full Text] [Related]
7. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
[TBL] [Abstract][Full Text] [Related]
9. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
10. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.
Hassman LM; Ellison TJ; Kedes DH
J Clin Invest; 2011 Feb; 121(2):752-68. PubMed ID: 21245574
[TBL] [Abstract][Full Text] [Related]
11. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
12. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
14. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
[TBL] [Abstract][Full Text] [Related]
15. Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells.
Landis JT; Tuck R; Pan Y; Mosso CN; Eason AB; Moorad R; Marron JS; Dittmer DP
mBio; 2022 Feb; 13(1):e0347321. PubMed ID: 35089062
[TBL] [Abstract][Full Text] [Related]
16. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
[TBL] [Abstract][Full Text] [Related]
17. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
[TBL] [Abstract][Full Text] [Related]
18. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.
Dollery SJ; Santiago-Crespo RJ; Kardava L; Moir S; Berger EA
J Virol; 2014 Feb; 88(3):1748-57. PubMed ID: 24257608
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication.
Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU
J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
